TT2-25210-52654
2 vaccinations
6 coded responses
18 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 740 / OK
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Registered in v-safe
-
2020-12-20
Dose 1 — Pfizer-BioNTech
- 2020-12-20
- 2020-12-21
- 2020-12-22
-
2020-12-29
Health check-in — day 7, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2020-12-29
- 2021-01-03
-
2021-01-10
Dose 2 — Pfizer-BioNTech
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion — Feeling: FairFree text: nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: FairFree text: Nasal congestion and sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Upper respiratory tract congestion — Feeling: GoodFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Survey response — day 7, dose 2MedDRA: Respiratory tract congestion — Feeling: FairFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
- 2021-01-31
- 2021-02-07
- 2021-02-14
-
2021-02-21
Survey response — day 42, dose 2MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: One migraine headache.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
-
2021-07-11
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous, Pregnancy — Feeling: GoodFree text: Two early term miscarriagesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2022-01-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-10 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-29 | priority 2/3 | |
| 2021-01-12 | priority 2/3 |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): nasal congestion
Systemic reaction (other): Nasal congestion and sore throat
Systemic reaction (other): Congestion
Release 2 — day 7, dose 2
Systemic reaction (other): Congestion
Release 4 — day 42, dose 2
Symptoms: One migraine headache.
Release 9 — 6 months, dose 2
Symptoms: Two early term miscarriages
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Upper respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release